"Isolate Id","Study","Species","Organism Group","Country","State","Gender","Age Group","Speciality","Source","In / Out Patient","Year","Phenotype","MIC","breakpoint","Drug"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.5","Susceptible","Amikacin"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,">32","Resistant","Amoxycillin clavulanate"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"16","Intermediate","Ampicillin"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"<=0.12","Susceptible","Cefepime"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.5","Susceptible","Ceftazidime"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.12","Susceptible","Ceftriaxone"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.5","Susceptible","Imipenem"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.12","Susceptible","Levofloxacin"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.03","Susceptible","Meropenem"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"2","Susceptible","Piperacillin tazobactam"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.5","Susceptible","Tigecycline"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.12","Susceptible","Aztreonam"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.25","Susceptible","Ceftaroline"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.25","Susceptible","Ceftazidime avibactam"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.12","Susceptible","Doripenem"
"1739242","Inform","Enterobacter, non-speciated","Enterobacteriaceae","Japan",NA,"Male","65 to 84 Years","Other","CVS: Blood","Other","2017",NA,"0.5","Susceptible","Ceftolozane tazobactam"
